The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Treatment of irritable bowel syndrome: a review of randomised controlled trials
Open accessAbstract
Irritable bowel syndrome (IBS) is a common chronic disorder that is associated with significant disability and health care costs. The purpose of this paper is to review and assess published randomised controlled trials examining the clinical effectiveness of interventions for IBS for 1987–1998. A literature search was conducted to identify randomised controlled trials of IBS treatments: 45 studies were identified that described randomised controlled trials and of these, six fulfilled all three criteria used to assess the quality of randomised controlled trials, as described by Jadad and colleagues. 1 These criteria are: adequate description of randomisation, double blinding, and description of withdrawals and dropouts. It is concluded that there are few studies which offer convincing evidence of effectiveness in treating the IBS symptom complex. This review strongly suggests that future work should include well designed trials that: describe the randomisation method; use internationally approved diagnostic criteria; and are double blinded and placebo controlled. Clear well defined outcome measures are necessary. Inclusion of quality of life measures allows comparison between trials in different therapeutic areas. Conducting such studies will help to overcome some of the difficulties identified in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Jadad, A. R., Nichol, G., Penman, M., Tugwell, P., & Walsh, S. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00031-w · Cited by 1,308 · cited 1×
“52 However, it was felt that very few Abbreviations used in this paper : IBS, irritable bowel syndrome; RCT, randomised controlled trial G l o b a l e va l u a t i o n , e a s e o f p a ss a g e , b l o a t i n g , n a u s e a , p a i n P o l y c a r b o ph y ll w a s r a t e d b e tt e r t h a n p…”
Background
Cited by
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384
Management of functional somatic syndromes
Henningsen, P., Zipfel, S., & Herzog, W. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60159-7 · Cited by 741
A Primer on Effectiveness and Efficacy Trials
Singal, A. G., Higgins, P. D. R., & Waljee, A. K. (2014) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2013.13 · Cited by 698
Shepherd, S. J., Parker, F. C., Muir, J. G., & Gibson, P. R. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.058 · Cited by 549
Lagattolla, N. (2002) · Key Topics in General Surgery · doi:10.1201/b14719-46 · Cited by 521
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
Saha, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6759 · Cited by 500
Fiber and Functional Gastrointestinal Disorders
Eswaran, S., Muir, J., & Chey, W. D. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.63 · Cited by 436
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389
Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome
Bijkerk, C. J., Muris, J. W. M., Knottnerus, J. A., Hoes, A. W., & De Wit, N. J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.0269-2813.2004.01862.x · Cited by 326
Irritable bowel syndrome: A clinical review
Soares, R. L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12144 · Cited by 266
Craske, M. G., Wolitzky-Taylor, K. B., Labus, J., Wu, S., Frese, M., Mayer, E. A., & Naliboff, B. D. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.04.001 · Cited by 243
Sibelli, A., Chalder, T., Everitt, H., Workman, P., Windgassen, S., & Moss-Morris, R. (2016) · Psychological Medicine · doi:10.1017/s0033291716001987 · Cited by 196
Quartero, A. O., Meiniche-Schmidt, V., Muris, J., Rubin, G., & de Wit, N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub2 · Cited by 190
Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits
Camilleri, M., Lembo, A., & Katzka, D. A. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.05.014 · Cited by 176
“Loperamide, a synthetic peripheral mu opioid receptor agonist, is efficacious in the treatment of diarrhea in IBS patients, delaying intestinal transit,(74) significantly decreasing stool frequency, increasing water and ion absorption, and improving stool consistency and urgency.(75) Its advantage over other m opioids…”
Dorn, S. D., Kaptchuk, T. J., Park, J. B., Nguyen, L. T., Canenguez, K., Nam, B. H., Woods, K. B., Conboy, L. A., Stason, W. B., & Lembo, A. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00937.x · Cited by 119
Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome
Giannini, E. G., Mansi, C., Dulbecco, P., & Savarino, V. (2006) · Nutrition · doi:10.1016/j.nut.2005.10.003 · Cited by 117
TSUCHIYA, J., BARRETO, R., OKURA, R., KAWAKITA, S., FESCE, E., & MAROTTA, F. (2004) · Chinese Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2004.00176.x · Cited by 108
Kennedy, T., Chalder, T., McCrone, P., Darnley, S., Knapp, M., Jones, R., & Wessely, S. (2006) · Health Technology Assessment · doi:10.3310/hta10190 · Cited by 92
Niv, E., Halak, A., Tiommny, E., Yanai, H., Strul, H., Naftali, T., & Vaisman, N. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0070-5 · Cited by 75
Smith, G. D. (2006) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2006.01356.x · Cited by 50
Shang, X., E, F.-F., Guo, K.-L., Li, Y.-F., Zhao, H.-L., Wang, Y., Chen, N., Nian, T., Yang, C.-Q., Yang, K.-H., et al. (2022) · Nutrients · doi:10.3390/nu14122482 · Cited by 41
“In addition, the accuracy and extrapolation of the results could be improved by limiting the patient subgroups in trials to improve the homogeneity of the subjects when designing trials [59,60].”
BackgroundThe Use of Probiotics in Functional Bowel Disease
Quigley, E. M. M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.05.008 · Cited by 20
“IBS continues to represent a significant therapeutic challenge; currently available therapies provide symptomatic relief, at best, and none have been shown to alter the natural history of the disorder [1,2,6–11].”
BackgroundWang, W., Wang, F., Fan, F., Sedas, A. C., & Wang, J. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9589-0 · Cited by 7
Metadata
- Authors
- AKEHURST, R., & KALTENTHALER, E.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2001-02-01
- Volume
- 48
- Issue
- 2
- Pages
- 272-282
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2020862319
- Cited by
- 165
- References
- 1
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.